Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol mebutate versus podophyllin for anogenital warts
IRCT20180715040482N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2017
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of ingenol mebutate and podophyllin in anogenital warts (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Frequency of therapy use for complete treatment, Duration of disease and 2 more. Started Dec 2017; status: completed.
02
Drugs
ingenol mebutatepodophyllin
03
Conditions
anogenital warts
Beyond the preview
Go deeper on IRCT20180715040482N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180715040482N1.